Form 4 for PCVX Vaxcyte, Inc.
Accepted 2024-12-03 00:00:00 ET · period of report 2024-12-02 · accession 0001649094-24-000114 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-12-03 | 2024-12-02 | PCVX | Wassil Jim | COO | S - Sale+OE | $92.49 | -8,000 | 206.8K | -4% | -$739.9K |
| D | 2024-12-03 | 2024-12-02 | PCVX | Wassil Jim | COO | M - OptEx | $2.42 | +8,000 | 213.7K | +4% | +$19.4K |
| D | 2024-12-03 | 2024-12-02 | PCVX | Wassil Jim | COO | M - OptEx | $0.00 | -8,000 | 18.6K | -30% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-02 | S | D | 1,127 | $94.06 | 205,695 | D | — | — | (F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $93.75 to $94.45. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2024-12-02 | M | A | 8,000 | $2.42 | 213,695 | D | — | — | |
| 3 | Common | Common Stock | 2024-12-02 | S | D | 5,772 | $92.07 | 207,923 | D | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $91.68 to $92.67. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2024-12-02 | S | D | 1,101 | $93.06 | 206,822 | D | — | — | (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $92.70 to $93.65. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 5 | Derivative | Stock Option (right to buy) | 2024-12-02 | M | D | 8,000 | $0.00 | 18,638 | D | $2.42 · — to 2029-12-16 | 8,000 Common Stock | (F5) 1/4 of the shares subject to the option vested on December 1, 2020, and 1/48 of the shares vest monthly thereafter. |